Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications
RSC Advances · 2026 · 16 (24) · 21967-22005
DOI: 10.1039/d6ra00737f ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Advances, 2026. Verfasst von Chetna Jadala und 4 weiteren Autor:innen. Beteiligte Einrichtung: Indiana University School of Medicine, Indiana University (IU) Indianapolis 46202 IN USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Nitrogen-containing heterocycles (N-Hets) are among the most prevalent and versatile structural motifs in pharmaceuticals, serving as key scaffolds in over 85% of biologically active small molecules.
Autor:innen und Institutionen
- Indiana University School of Medicine, Indiana University (IU) Indianapolis 46202 IN USA.
- Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research Sant Tukaram Nagar, Pimpri Pune 411018 India.
- DPGU - School of Pharmacy and Research Sant Tukaram Nagar, Pimpri Pune 411018 India.
- Department of Chemistry and Biochemistry, The University of Oklahoma Norman Oklahoma 73019 USA.
- Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona Tucson 85721 AZ USA vgreddy@arizona.edu velmagangareddy47@gmail.com.
ORCID-Profile: Gal Reddy Potuganti, Ganga Reddy Velma
Zitieren
APA
Jadala, C., Mishra, S., Potuganti, G. R., Cardoza, S., & Velma, G. R. (2026). Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications. RSC Advances, 16(24), 21967-22005. https://doi.org/10.1039/d6ra00737f
Vancouver
Jadala C, Mishra S, Potuganti GR, Cardoza S, Velma GR. Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications. RSC Advances. 2026;16(24):21967-22005. doi:10.1039/d6ra00737f
BibTeX
@article{Jadala2026,
author = {Jadala, Chetna and Mishra, Shweta and Potuganti, Gal Reddy and Cardoza, Savio and Velma, Ganga Reddy},
title = {Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {24},
pages = {21967--22005},
doi = {10.1039/d6ra00737f}
}
EUVIMED